Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · IEX Real-Time Price · USD
45.12
+0.35 (0.78%)
At close: Jul 19, 2024, 4:00 PM
45.17
+0.05 (0.11%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $4.32 billion as of July 22, 2024. Its market cap has increased by 465.25% in one year.
Market Cap
4.32B
Enterprise Value
3.41B
1-Year Change
465.25%
Ranking
Category
Stock Price
$45.12
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $939.10M to $4.32B, an increase of 359.50%. That is a compound annual growth rate of 45.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 4.32B | 543.47% |
| Dec 29, 2023 | 670.60M | -44.51% |
| Dec 30, 2022 | 1.21B | 8.41% |
| Dec 31, 2021 | 1.11B | 16.39% |
| Dec 31, 2020 | 957.70M | 1.98% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransMedics Group | 4.85B |
| CRISPR Therapeutics AG | 4.63B |
| Apellis Pharmaceuticals | 4.61B |
| RadNet | 4.58B |
| Haemonetics | 4.52B |
| Inspire Medical Systems | 4.27B |
| Integer Holdings | 4.23B |
| Alkermes | 4.20B |